The Federal and Drug Administration (FDA) has approved a generic form of mifepristone.
On Tuesday, the federal agency sent a letter to Evita Solutions to inform the company its drug application met the necessary requirements for approval.
The drug now becomes the second generic version to hit the market.
“The
Continue reading
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!